Delivery Order SPE2DB22D2007-SPE2DB24FH9AV
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product, in Conshohocken, PA. The $4,281.68 contract has a completion date of February 15, 2024 and was awarded on February 14, 2024. This delivery order is part of Amerisourcebergen Drug Corp's larger indefinite delivery contract with DLA, valued at up to $999,999,999.00 through...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $3,007.71 contract is for the delivery of RINVOQ ER 15 MG TABLET, a pharmaceutical product, with a completion date of February 14, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which was not set aside for any particular business type....
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, to provide RINVOQ ER 30 MG TABLET UU 30S. The contract has a potential value of $16,973.25 and a performance period through January 29, 2024. Amerisourcebergen Drug Corporation is the prime contractor, with no set-aside designation indicated. This delivery order is issued under a larger indefinite...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $10,702.11 to Amerisourcebergen Drug Corp, a for-profit organization, to provide the pharmaceutical product RINVOQ ER 15 MG TABLET UU 30S. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract has a potential value of $27,175.99 and a completion date of March 1, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is issued under an indefinite delivery contract (IDC) valued at up to $999,999,999.00...
- The Defense Logistics Agency (DLA) awarded a $6,360.11 firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to supply RINVOQ ER 30 MG TABLET. The delivery order has a completion date of February 9, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 and a performance period through...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract, valued at $7,275.16, to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of the pharmaceutical product RINVOQ ER 30 MG TABLET UU 30S. The contract has a period of performance through March 12, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a separate $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA, which serves as the...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $6,015.42 to Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania. The contract is for the supply of RINVOQ ER 15 MG TABLET with a completion date of February 16, 2024. Amerisourcebergen Drug Corp is a for-profit subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The company serves as a...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $13,866.16 contract is for the supply of the prescription drug RINVOQ ER 15 MG TABLET. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations for this award. The contract has a completion date of February 7, 2024 and was awarded on February 6, 2024....
- The Defense Logistics Agency awarded a $6,558.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on December 8, 2025, with completion targeted for December 9, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FH9AVDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RINVOQ ER 45 MG TABLET in quantities of 28. The completion date for this $6,863.94 contract is January 30, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and will fulfill this order from its Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract with DLA, valued at up to $999,999,999.00, to provide pharmaceuticals and medical supplies to support Department of Defense military treatment programs and facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 1/29/24 |